Orphazyme raises €80m in oversubscribed IPO
Summary
Following extensive engagement with industry and stakeholders, the new "National Vision for Engineering Biology" lays out the governments...Finnish Biovian Oy and Pamplona-based 3P Biopharmaceuticals Srl have joined forces to build a pan-European Contract Development and Manufacturing...Upon closure, the US$425m take-over of the Amsterdam-headquartered Calypso Biotech NV, would give Novartis AG full commercialisation rights to...Alvotech SA, a global biotech company from Luxembourg, specialising in biosimilars, reported positive results from a pharmacokinetic study of AVT03,...The new factory will have a production capacity of around 3 million kilograms a year equal to the amount of protein from 30,000 cows but with...The company announced that the funding will be used to expand Metrions new (2021) laboratories in Cambridge, UK, invest in specialist...The long-standing governing party is doing the same as Italy with its motion and is calling for "a ban on the production, processing and...